CVRx (CVRX) Competitors $11.72 -0.55 (-4.48%) Closing price 04/4/2025 04:00 PM EasternExtended Trading$11.71 -0.01 (-0.09%) As of 04/4/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CVRX vs. TNDM, LQDA, KMTS, INMD, CDRE, ESTA, MDXG, FNA, BLFS, and AORTShould you be buying CVRx stock or one of its competitors? The main competitors of CVRx include Tandem Diabetes Care (TNDM), Liquidia (LQDA), Kestra Medical Technologies (KMTS), InMode (INMD), Cadre (CDRE), Establishment Labs (ESTA), MiMedx Group (MDXG), Paragon 28 (FNA), BioLife Solutions (BLFS), and Artivion (AORT). These companies are all part of the "medical equipment" industry. CVRx vs. Tandem Diabetes Care Liquidia Kestra Medical Technologies InMode Cadre Establishment Labs MiMedx Group Paragon 28 BioLife Solutions Artivion Tandem Diabetes Care (NASDAQ:TNDM) and CVRx (NASDAQ:CVRX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, community ranking, dividends, media sentiment, risk, valuation, profitability and analyst recommendations. Which has more volatility & risk, TNDM or CVRX? Tandem Diabetes Care has a beta of 1.45, meaning that its share price is 45% more volatile than the S&P 500. Comparatively, CVRx has a beta of 1.34, meaning that its share price is 34% more volatile than the S&P 500. Is TNDM or CVRX more profitable? Tandem Diabetes Care has a net margin of -14.84% compared to CVRx's net margin of -116.91%. Tandem Diabetes Care's return on equity of -44.19% beat CVRx's return on equity.Company Net Margins Return on Equity Return on Assets Tandem Diabetes Care-14.84% -44.19% -11.99% CVRx -116.91%-93.06%-51.78% Does the MarketBeat Community favor TNDM or CVRX? Tandem Diabetes Care received 554 more outperform votes than CVRx when rated by MarketBeat users. However, 73.33% of users gave CVRx an outperform vote while only 61.02% of users gave Tandem Diabetes Care an outperform vote. CompanyUnderperformOutperformTandem Diabetes CareOutperform Votes58761.02% Underperform Votes37538.98% CVRxOutperform Votes3373.33% Underperform Votes1226.67% Do analysts recommend TNDM or CVRX? Tandem Diabetes Care presently has a consensus price target of $45.38, suggesting a potential upside of 168.81%. CVRx has a consensus price target of $17.83, suggesting a potential upside of 52.16%. Given Tandem Diabetes Care's higher possible upside, research analysts clearly believe Tandem Diabetes Care is more favorable than CVRx.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Tandem Diabetes Care 0 Sell rating(s) 7 Hold rating(s) 11 Buy rating(s) 0 Strong Buy rating(s) 2.61CVRx 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.86 Does the media prefer TNDM or CVRX? In the previous week, Tandem Diabetes Care had 7 more articles in the media than CVRx. MarketBeat recorded 8 mentions for Tandem Diabetes Care and 1 mentions for CVRx. CVRx's average media sentiment score of 1.79 beat Tandem Diabetes Care's score of 1.44 indicating that CVRx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tandem Diabetes Care 5 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive CVRx 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Which has higher valuation and earnings, TNDM or CVRX? CVRx has lower revenue, but higher earnings than Tandem Diabetes Care. Tandem Diabetes Care is trading at a lower price-to-earnings ratio than CVRx, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTandem Diabetes Care$940.20M1.19-$222.61M-$1.46-11.56CVRx$51.29M5.95-$59.97M-$2.69-4.36 Do insiders and institutionals hold more shares of TNDM or CVRX? 75.3% of CVRx shares are held by institutional investors. 2.2% of Tandem Diabetes Care shares are held by insiders. Comparatively, 18.9% of CVRx shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryTandem Diabetes Care beats CVRx on 10 of the 18 factors compared between the two stocks. Remove Ads Get CVRx News Delivered to You Automatically Sign up to receive the latest news and ratings for CVRX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CVRX vs. The Competition Export to ExcelMetricCVRxSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$305.14M$3.99B$5.26B$7.12BDividend YieldN/A40.98%4.89%4.08%P/E Ratio-4.3627.2321.3817.51Price / Sales5.9546.42355.0688.78Price / CashN/A51.7738.1834.64Price / Book4.295.706.233.79Net Income-$59.97M$67.02M$3.21B$247.48M7 Day Performance-6.16%-8.78%-8.47%-6.79%1 Month Performance-6.09%-9.94%-4.87%-11.53%1 Year Performance-33.71%4.99%2.54%-7.82% CVRx Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CVRXCVRx2.0411 of 5 stars$11.72-4.5%$17.83+52.2%-32.6%$305.14M$51.29M-4.36160Positive NewsGap DownTNDMTandem Diabetes Care4.4132 of 5 stars$19.16-0.6%$45.38+136.8%-49.1%$1.27B$940.20M-9.932,600News CoveragePositive NewsGap DownLQDALiquidia2.3489 of 5 stars$14.75-2.3%$26.63+80.5%-15.7%$1.26B$14.00M-9.0550Gap DownKMTSKestra Medical TechnologiesN/A$24.92+6.4%$27.67+11.0%N/A$1.23B$45.82M0.00300INMDInMode2.3914 of 5 stars$17.74+0.2%$22.25+25.4%-20.8%$1.23B$394.82M7.55480News CoveragePositive NewsGap DownCDRECadre3.6122 of 5 stars$29.69+2.1%$37.00+24.6%-21.5%$1.21B$567.56M35.772,240Gap DownESTAEstablishment Labs1.8732 of 5 stars$40.81+0.9%$57.40+40.7%-38.7%$1.18B$166.03M-15.82960Positive NewsGap DownMDXGMiMedx Group3.0006 of 5 stars$7.60+0.8%$12.00+57.9%+0.6%$1.12B$348.88M13.82870Analyst UpgradeNews CoveragePositive NewsFNAParagon 281.2456 of 5 stars$13.05+0.0%$14.20+8.9%+28.0%$1.09B$256.18M-17.63343,000BLFSBioLife Solutions1.6216 of 5 stars$22.84-12.0%$29.86+30.7%+19.2%$1.07B$82.25M-21.55440Insider TradeNews CoveragePositive NewsGap DownHigh Trading VolumeAORTArtivion3.2957 of 5 stars$24.63+1.6%$31.40+27.5%+9.2%$1.04B$388.54M-1,231.651,300Positive NewsGap Down Remove Ads Related Companies and Tools Related Companies TNDM Competitors LQDA Competitors KMTS Competitors INMD Competitors CDRE Competitors ESTA Competitors MDXG Competitors FNA Competitors BLFS Competitors AORT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CVRX) was last updated on 4/5/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredBrace Yourself for Jeff Bezos’ “Amazon Helios”Jeff Bezos quietly backing world-changing tech (not AI) The Amazon founder is quietly advancing a radical t...Stansberry Research | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CVRx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CVRx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CVRX Stock Free CVRX Stock Alerts